LDOC1 Antikörper (AA 65-146) (HRP)
Kurzübersicht für LDOC1 Antikörper (AA 65-146) (HRP) (ABIN717845)
Target
Alle LDOC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 65-146
-
Homologie
- Human,Dog,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LDOC1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))
-
Andere Bezeichnung
- LDOC1
-
Hintergrund
-
Synonyms: Mar7, BCUR1, Mart7, Protein LDOC1, Leucine zipper protein down-regulated in cancer cells, LDOC1
Background: May have an important role in the development and/or progression of some cancers.
-
Gen-ID
- 23641
-
UniProt
- O95751
Target
-